Efficacy of the antiCD38 Monoclonal Antibody Isatuximab in the Treatment of PCRA by Major ABO Mismatch After Allogeneic Hematopoietic Stem Cell Transplantation

NCT05559827 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Immunological Pure Red Cell Aplasia

Interventions

DRUG: Isatuximab

Sponsor

Assistance Publique - Hôpitaux de Paris